Cleared Abbreviated

Bodycad Unicompartmental Knee System (K181302) - FDA 510(k) Clearance

Class II Orthopedic device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2019
Decision
245d
Days
Class 2
Risk

K181302 is an FDA 510(k) clearance for the Bodycad Unicompartmental Knee System. Classified as Prosthesis, Knee, Femorotibial, Non-constrained, Cemented, Metal/polymer (product code HSX), Class II - Special Controls.

Submitted by Bodycad Laboratories, Inc. (Quebec, CA). The FDA issued a Cleared decision on January 17, 2019 after a review of 245 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3520 - the FDA orthopedic device regulatory framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Bodycad Laboratories, Inc. devices

Submission Details

510(k) Number K181302 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 2018
Decision Date January 17, 2019
Days to Decision 245 days
Submission Type Abbreviated
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
123d slower than avg
Panel avg: 122d · This submission: 245d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code HSX Prosthesis, Knee, Femorotibial, Non-constrained, Cemented, Metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3520
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

BioVera, Inc.
Robert A. Poggie

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HSX Prosthesis, Knee, Femorotibial, Non-constrained, Cemented, Metal/polymer

All 69
Devices cleared under the same product code (HSX) and FDA review panel - the closest regulatory comparables to K181302.
EMPOWR Partial Knee
K191325 · Encore Medical, L.P. · Jul 2019
Journey II Unicompartmental Knee System
K190085 · Smith & Nephew, Inc. · Feb 2019
MOTO Partial Knee System
K183029 · Medacta International S.A. · Jan 2019
Materialise PKA Guide System
K173970 · Materialise NV · Jul 2018
Triathlon PKR X3 Tibial Inserts, Mako X3 Uni Onlay Tibial Inserts
K180612 · Howmedica Osteonics Corp. A.K.A. Stryker Orthopaedics · Jun 2018
GMK UNI
K161741 · Medacta International S.A. · Apr 2017